Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients de réir Cloud P. Paweletz (14960112)

Ábhair:

Table 1_Machine learning-based prediction of response to Janus kinase inhibitors in patients with rheumatoid arthritis using clinical data.docx de réir Yeo-Jin Lee (22687199)

Ábhair:

Supplementary Table S4 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts de réir Gabriele Todisco (15127828)

Ábhair:

Supplementary Table S2 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts de réir Gabriele Todisco (15127828)

Ábhair:

Supplementary Table S1 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts de réir Gabriele Todisco (15127828)

Ábhair:

Supplementary Table S3 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts de réir Gabriele Todisco (15127828)

Ábhair:

Supplementary Table S5 from Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts de réir Gabriele Todisco (15127828)

Ábhair:

Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma de réir Sied Kebir (15048732)

Ábhair:

Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma de réir Sied Kebir (15048732)

Ábhair:

Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma de réir Sied Kebir (15048732)

Ábhair:

Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Supplementary Figure S1 from Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101) de réir Roberto Carmagnani Pestana (15294422)

Ábhair:

Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry de réir Nadia Mezghani (15055724)

Ábhair:

Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma de réir Sied Kebir (15048732)

Ábhair:

Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair:

Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy de réir Laura Boucai (15054310)

Ábhair: